5
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Chemokines and central nervous system disorders

Pages 493-500 | Published online: 10 Jul 2009

References

  • Asensio VC, Lassmann S, Pagenstecher A, Steffensen SC, Henriksen SJ, Campbell IL (1999). C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol 154: 1181–1191.
  • Balashov KE, Rottman JB, Weiner HL, Hancock WW (1999). CCR5 + and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are ex-pressed in demyelinating brain lesions. Proc Nat] Acad Sci USA 96: 6873–6878.
  • Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640–644.
  • Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ (1997). The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 58: 52–59.
  • Charles PC, Weber KS, Cipriani B, Brosnan CF (1999). Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: im-plications for establishment of a Th1/Th2 bias. J Neuroimmunol 100: 64–73.
  • Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, Brack-Werner R, Poli G (2000). Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. JNeuroVirol 6: 75–83.
  • Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, Coit D, Merryweather J, Cerami A (1988). Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine proper-ties. J Exp Med 167: 1939–1944.
  • Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquist L, Wretlind B, Bakhiet M, Link H (1999). Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruit-ment in the central nervous system during experimental bacterial meningitis. Infect Immun 67: 2590–2601.
  • Fiala M, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE (1998). Amyloid-beta induces chemokine se-cretion and monocyte migration across a human blood-brain barrier model. Mol Med 4: 480–489.
  • Fife BT, Huffnagle GB, Kuziel WA, Karpus WJ (2000). CC chemokine receptor 2 is critical for induction of experi-mental autoimmune encephalomyelitis. I Exp Med 192: 899–906.
  • Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ (2001). CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617–7624.
  • Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM (1997). Impaired host defense, hematopoiesis, granulo-matous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185: 1959–1968.
  • Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, Bock P, Che M, Limoges J, Gendelman HE, Mackay CR (1998). Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 in-fection of monocytes and microglia. I Virol 72: 3351–3361.
  • Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM (1997). Synchronous synthesis of a- and, 8-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150: 617–630.
  • Glabinski AR, Tani M, Tuohy VK, Tuthill RJ, Ransohoff RM (1995). Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun 9: 315–330.
  • Glabinski AR, Tuohy VK, Ransohoff RM (1998). Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5: 166–171.
  • Godiska R, Chantry D, Dietsch GN, Gray PW (1995). Chemokine expression in murine experimental allergic encephalomyelitis. I Neuroimmunol 58: 167–176.
  • He JL, Chen YZ, Farzan M, Choe HY, Ohagen A, Gartner S, Busciglio J, Yang XY, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645–649.
  • Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu YM, Menon S, Abrams J, Handel T, Zlotnik A (1997). Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158: 1533–1540.
  • Hesselgesser J, Ng HP, Liang M, Zheng W, May K, Bauman JG, Monahan S, Islam I, Wei GP, Ghannam A, Taub DD, Rosser M, Snider RM, Morrissey MM, Perez HD, Horuk R (1998). Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 273: 15687–15692.
  • Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ (1999). Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J NeuroVirol 5: 635–642.
  • Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC (1997). Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882–2890.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.